Division of Hematology
Department of Medicine Compendium of Divisional Activity 2013-2014 — divisIon of HEMATOLOGY
87
DIVISION OF HEMATOLOGY
Physician Resources
Division Highlights
10 Hematologists (7.45 FTE)
Our Patient Care
•• 7 full-time
The Division continues to see, assess and care for a
large number of inpatients and outpatients. For the
2013-14 year, there were 2,107 new patients and 8,964
return patients seen in clinics, 10,826 patients assessed
and treated in MDU, 938 inpatient consultations, 656
admissions and 69 blood and marrow transplantations.
•• 3 part-time
Collaborative clinics at the IWK Health Center and in
Moncton and St. John’s continued on a monthly basis.
A new program for the management of patients with
venous thromboembolism who are prescribed novel oral
anticoagulants (NOACs) is under development with the
Emergency Department.
The Division of Hematology in Halifax has been cited more
than once in the last year as having the highest centre
accrual for both national and international studies.
The Division employs 17 full-time research staff through
grant and contract research support.
Our Education
Dr. Andrea Kew has stepped down as Program Director,
Hematology after completing a 6 year term. Under her
leadership, the program blossomed with 8 trainees and a
laudatory review from the Royal College.
Dr. Darrell White has stepped down as Program Director,
Internal Medicine after a very successful term. We are very
pleased to have him back!
Our Research
Dr. White was an author of the FIRST trial examining
lenalidomide and decadron in patients with myeloma.
This was presented at the Plenary Session of the American
Society of Hematology Meeting in 2013.
Dr. Anderson continues to lead the national CIHR-funded
EPCAT II study: Extended Venous Thromboembolism
Prophylaxis Comparing Rivaroxaban to Aspirin Following
Total Hip and Knee Arthroplasty.
Dr. Couban continues to lead the Terry Fox Research
Institute study looking at the role of novel biomarkers in
patients with MDS and AML.
Division members continue to participate in more than
40 active investigator-initiated and industry-sponsored
clinical trials in the management of patients with
hematologic cancer and venous thromboembolism.
88
Department of Medicine Compendium of Divisional Activity 2013-2014 — divisIon of HEMATOLOGY
Dr. Sudeep Shivakumar has stepped down as
Undergraduate Education Director and as leader of the
hematology section of the undergraduate curriculum.
Welcome to Dr. Mary-Margaret Keating in her new role as
Undergraduate Education Director (February 2014) and to
Dr. Sudeep Shivakumar in his new role as Postgraduate
Program Director (January 2014).
Dr. Katherine MacInnes was accepted to the Hematology
Fellowship Training Program to start on July 1, 2014.
The Division hosted 7 distinguished speakers in 2013-14:
including Drs. Margaret Rand, Andrew Davies, Thomas
Nevill, David Chui, Dick Wells, Peter Lin and Cyrus Hsia.
The Division includes 7 full-time hematologists (Drs. David
Anderson, Stephen Couban, Andrea Kew, David Macdonald,
Sue Robinson, Sudeep Shivakumar and Darrell White) and
4 part-time hematologists (Drs. Wanda Hasegawa, Ormille
Hayne, Mary-Margaret Keating and Andrew Padmos).
The team works collaboratively with Capital District
Health Authority staff including individuals from nursing,
pharmacy, social work, psychological and spiritual
supports.
The Division is supported by four administrative assistants
including team leader, Ms. Cheryl Peever.
Welcome back to Sveta Withrow who rejoins our Division.
Fond farewell and best wishes to Randi Griffin.
New Programs, Partnerships &
Innovations
Dr. Sudeep Shivakumar is working with Dr. Sam Campbell
and the Department of Emergency Medicine to develop
a new treatment approach for patients diagnosed with
venous thromboembolism who can be treated with a novel
oral anticoagulant. This will reduce the number of urgent
referrals to the Hematology Clinic.
Dr. Couban continues to collaborate with Dr. David Simpson
and his colleagues in the Division of General Internal
Medicine in redirecting referrals for anemia from the
Division of Hematology to the Division of General Internal
Medicine since many patients with anemia have problems
best assessed and managed by a general internist
(approximately 10-15 patients per month).
Dr. Mary-Margaret Keating has joined Dr. Sue Robinson in
a collaborative Bleeding Disorders Clinic. Dr. Robinson is
a recognized national expert in bleeding disorders and has
led the CDHA Bleeding Disorders Clinic for many years.
Dr. Keating is a welcome addition who will increase our
capacity to see patients with bleeding disorders.
Work for Nova Scotia
Department of Health &
Wellness
Dr. Anderson continues to co-lead the Nova Scotia
Provincial Blood Coordinating Program.
Quality & Patient Safety
Dr. Wanda Hasegawa is the medical lead of the process
at the Capital District Health Authority for the Blood and
Marrow Transplant Program to achieve Foundation for
Accreditation of Cellular Therapy (FACT) accreditation.
This is an international standard which all transplantation
centers will be required to achieve in order to continue to
perform transplantation procedures. She has also been
the medical lead to prepare for accreditation by Health
Canada.
In addition, Dr. Hasegawa chairs the Hematology Quality
Committee and leads quarterly Morbidity and Mortality
Rounds. Under her supervision, members of the Division
review all deaths of inpatients on the hematology service
and other morbidity and mortality events as appropriate.
The Division continues to undertake certain types
of autologous and allogeneic transplantation on an
outpatient basis. In addition, Day 1 transfer of recipients
of autologous transplant to Moncton General Hospital
continue. Efforts are underway to replicate this process
for patients returning to the George Dumont Hospital
in Moncton. Division members continue to work with
colleagues in nursing, pharmacy and social work to
expedite discharges and facilitate appropriate transfers
and discharges.
Public Education
Members of the Division participate in public education
endeavors including participating in the advisory boards of
patient advocacy groups such as the Aplastic Anemia and
Myelodysplasia Society (Stephen Couban) and Myeloma
Canada (Darrell White).
Department of Medicine Compendium of Divisional Activity 2013-2014 — divisIon of HEMATOLOGY
89
DIVISION OF HEMATOLOGY
Our Team
Division members provide secondary, tertiary and
quaternary care for patients with benign and malignant
hematological disorders. This includes the administration
of chemotherapy and stem cell transplantation procedures
for patients with leukemia, lymphoma and multiple
myeloma, along with diagnostic and therapeutic services
for patients with thromboembolic and major bleeding
disorders. The Division runs an inpatient service at the
Victoria General site as well as delivering outpatient care
through the Hematology Clinic and Medical Day Unit and
through satellite clinics in Moncton, Sydney, St John’s and
the IWK Health Centre.
20
Unit/Designation
Beds
8A/8B General Hematology & BMT
20
15
Current and historical occupancy rates and bed utilization
on Hematology and BMT Nursing Units have been merged
to more fully reflect the Hematology Inpatient services
in this report. The average occupancy rate (according
to midnight census) for 2013-14 was 96.7%. The bed
utilization shows an average of 18.1 beds used, with 18.7
available.
Figure 1
Hematology
Inpatient Bed Average Occupancy Rate by Fiscal Year
QEII Health Sciences Centre, 2009 - 2014
120%
95.9%
Hematologists provided 24-hour, 7-day / week emergency
and on-call inpatient consultation service for the QEII
Health Sciences Centre (QEII HSC). Hematologists provided
advice and urgent consultation services to physicians in
the Maritime Provinces.
Hematology
Average Bed Utilization by Fiscal Year
QEII Health Sciences Centre, 2009 - 2014
Table 1
100%
Emergency Coverage
Figure 2
Beds
Clinical Services
There are 20 inpatient beds designated to the General
Hematology Service and the Blood and Marrow Transplant
(BMT) Service.
94.7%
97.0%
100.5%
96.7%
80%
10
5
0
Total Used
Available
2009-2010
16.6
17.3
2010-2011
17.3
18.3
2011-2012
18.3
18.8
Source: STAR Data
2012-2013
18.7
18.6
2013-2014
18.1
18.7
Prepared by DOM Information Office
465 patients were admitted to the Hematology Inpatient
Services during 2013-14, representing a 6.8% decrease
from the previous year. Additionally, 191 patients were
transferred to Hematology care from other parts of the QEII
HSC for a total of 656 admissions and transfers for the
year. Average Length of Stay (ALOS) was 14.3 days.
Figure 3
Hematology
Inpatient Admissions and Transfers In by Fiscal Year
QEII Health Sciences Centre, 2009 - 2014
60%
800
700
40%
20%
0%
2009-2010
Source: STAR Data
2010-2011
2011-2012
2012-2013
2013-2014
Prepared by DOM Information Office
Admissionns and Transfers
Issues of appropriateness of care continue to be addressed
through quarterly reviews of morbidity and mortality
supervised by Dr. Wanda Hasegawa.
Inpatient Services (General Hematology and BMT)
Percent Occupancy
DIVISION OF HEMATOLOGY
Issues of Appropriateness of
Care
600
500
400
300
200
100
0
Tranfers In
Admits
Total
Source: STAR Data
90
Department of Medicine Compendium of Divisional Activity 2013-2014 — divisIon of HEMATOLOGY
2009-2010
190
504
694
2010-2011
188
484
672
2011-2012
172
472
644
2012-2013
205
511
716
2013-2014
191
465
656
Prepared by DOM Information Office
Blood and Marrow Transplant
Program (BMT)
Figure 6
Hematology Inpatient Admissions
Summary Distribution of Patient Residency by Health District
QEII Health Sciences Centre, 2013 - 2014
Hematology
Inpatient Average Length of Stay (Days) by Fiscal Year
QEII Health Sciences Centre, 2009 - 2014
16
The Blood and Marrow Transplant program has served
patients throughout the Maritimes since 1992. There were
107 blood and marrow transplants completed in 2013-14,
an increase of 9.2% from the previous year.
Out of Province: 80
14
14.5
12
13.1
12.5
12.0
14.3
Capital District: 199
Days
10
8
Figure 8
6
4
Blood and Marrow Transplant
QEII Health Sciences Centre, 2009 - 2014
Non Capital District:
186
2
120
0
100
2010-2011
Source: STAR Data
2011-2012
2012-2013
2013-2014
Prepared by DOM Information Office
Of the Hematology inpatient admissions in 2013-14, 59%
were male and 41% were female. 40.0% of admissions
came from Nova Scotia Health Districts outside of Capital
while an additional 17.2% came from other Atlantic
Provinces. These ratios are reflective of the tertiary and
quaternary nature of the service.
Source: STAR Data
Figure 7
60
40
20
0
Hematology Inpatient Admissions
Distribution of Patient Residency by Atlantic Province
QEII Health Sciences Centre, 2013 - 2014
Autologous
Related Allogenic Myeloablative
Related Non-Myeloablative
Matched Unrelated Myeloablative
Matched Unrelated NonMyeloablative
Syngenic Transplant
Total
Newfoundland: 9
Figure 5
80
Prepared by DOM Information Office
Transplants
2009-2010
Source: Data Administrator, Oncology Services
Prince Edward Island:
33
20092010
47
10
6
7
20102011
51
22
7
9
20112012
52
9
16
7
20122013
48
12
5
16
20132014
62
13
4
6
12
17
25
74
95
1
97
98
107
7
Prepared by DOM Information Office
Nova Scotia: 386
Hematology Inpatient Admissions
Percent Distribution by Gender
QEII Health Sciences Centre, 2013 - 2014
New Brunswick: 36
Female
41%
Source: STAR Data
Prepared by DOM Information Office
Male
59%
Source: STAR Data
Prepared by DOM Information Office
Department of Medicine Compendium of Divisional Activity 2013-2014 — divisIon of HEMATOLOGY
91
DIVISION OF HEMATOLOGY
Figure 4
Ambulatory Care
Special Service Commitments
The figure below depicts a combination of activity on the
Hematology Inpatient Consult service and service to the
Medical Teaching Unit (MTU) and Internist Emergency
Department Call Rotation by division members over the
past 5 years. There were 938 inpatient consults at the
QEII Health Sciences Centre reported for Hematologists
in 2013-2014, representing a 5.0% decrease from the
previous year.
There were 11,095 patient registrations to the six subspecialty outpatient services during 2013-14, which
represents a 2.8% increase relative to the previous year.
Of the 2013-14 clinic visits, 19.0% were new consults.
Patients undergoing chemotherapy require many return
visits. Data includes visits to non-physicians such as
nursing and pharmacy. There were an additional 2,740
chart checks performed in 2013-14 not reported in the
following figures.
Figure 10
109 patients were seen in the Moncton BMT Clinic during
2013-14.
Figure 12
Hematology Clinic Visits
Moncton Clinics, 2009 - 2014
175
150
125
Visits
Figure 9
Hematology Inpatient Consults
QEII Health Sciences Centre, 2009 - 2014
Hematology Ambulatory Care Registrations
QEII Health Sciences Centre & Cobequid Community Health Centre
2009 - 2014
1,200
100
75
50
12,000
1,054
25
10,000
987
956
896
800
938
Registrations
1,000
# Consullts
600
8,000
0
6,000
New
Return
Total
% New
4,000
2,000
0
400
Autologous B
Hereditary Bleeding Disease
Blood & Marrow Transplant
Deep Vein Thrombosis
Hematology
Oncology
Total
200
0
2009-2010
Source: Physician Services
2010-2011
2011-2012
2012-2013
2013-2014
Prepared by DOM Information Office
2009-2010
2
126
128
1.6%
2010-2011
6
115
121
5.0%
2011-2012
1
153
154
0.6%
Source: Divisional Data
20092010
239
585
1,081
2,647
5,087
9,639
20102011
1
415
685
970
3,347
5,265
10,683
20112012
33
443
811
1,137
2,588
5,954
10,966
20122013
33
412
622
1,144
2,064
6,520
10,795
Source: STAR Data
20132014
1
323
657
1,129
2,085
6,900
11,095
2012-2013
1
152
153
0.7%
2013-2014
0
109
109
0.0%
Prepared by DOM Information Office
105 patients were seen in the Newfoundland and Labrador
BMT Clinic during 2013-14.
Figure 13
Prepared by DOM Information Office
Figure 11
Hematology Clinic Visits
St. John's, Newfoundland, 2009 - 2014
175
Hematology New and Return Ambulatory Care Registrations
QEII Health Sciences Centre & Cobequid Community Health Centre
2009 - 2014
150
125
14,000
# Visits
12,000
10,000
Regiistrations
DIVISION OF HEMATOLOGY
Inpatient Consultations
75
8,000
50
6,000
25
4,000
0
2,000
New
Return
Total
% New
0
New
Return
Total
% New
Source: STAR Data
92
100
Department of Medicine Compendium of Divisional Activity 2013-2014 — divisIon of HEMATOLOGY
2009-2010
2,238
7,992
10,230
21.9%
2010-2011
2,890
8,555
11,445
25.3%
2011-2012
2,570
9,539
12,109
21.2%
2012-2013
2,014
8,781
10,795
18.7%
2013-2014
2,107
8,988
11,095
19.0%
Prepared by DOM Information Office
2009-2010
18
144
162
11.1%
Source: Divisional Data
2010-2011
9
109
118
7.6%
2011-2012
21
95
116
18.1%
2012-2013
17
122
139
12.2%
2013-2014
18
87
105
17.1%
Prepared by DOM Information Office
Wait Times & Outpatient Through-put
All patients referred to the Division of Hematology are triaged centrally by a Hematologist. Urgency is assigned using criteria
in the table below. It should be noted that effective October 2009 the division began a pilot providing written advice to
referring physicians in place of a clinic visit for certain less-urgent referrals.
Figure 14
Hematology Clinic Visits
IWK PNC Hematology Clinics, 2009 - 2014
70
60
AAxis Title
50
40
30
20
10
0
New
Return
Total
% New
Source: Meditech
2009-2010
27
17
44
61.4%
2010-2011
35
31
66
53.0%
2011-2012
24
16
40
60.0%
2012-2013
30
12
42
71.4%
2013-2014
30
17
47
63.8%
Prepared by DOM Information Office
Guidelines for Triage of New Referrals to Hematology Outpatient Clinics
Standard Wait Time
Emergent (C1)
Examples include:
–– New diagnosis of acute Leukemia
–– Severe thrombocytopenia
–– Severe Anemia
–– Severe Leukopenia
Within 48 hours
Urgent (C2)
Examples include:
–– New diagnosis of Lymphoma/Hodgkin’s disease
Within 2 weeks (14 days)
Semi-urgent (C3)
Examples include:
–– New diagnosis of Myeloma
–– Moderate Anemia, Moderate Thrombocytopenia
–– New diagnosis of chronic myeloid leukemia (stable)
Within 6 weeks (42 days)
Non-urgent (C4)
Examples include:
–– Homozygous HFE C282Y Hemachromatosis
–– Mild cytopenias
–– Duration of anticoagulation
–– New diagnosis of chronic lymphocytic leukemia (stable)
–– Personal or Family History of previous thrombosis
Within 13 weeks (90 days)
Department of Medicine Compendium of Divisional Activity 2013-2014 — divisIon of HEMATOLOGY
93
DIVISION OF HEMATOLOGY
47 patients were seen in the High-Risk Pregnancy Clinic
for Women with Hematological Disorders at the IWK Health
Centre in 2013-14.
Figure 17
Hematology Emergent Consult
Ambulatory Care Clinic Average Wait Time (Days) by Quarter
QEII Health Sciences Centre, 2012 - 2014
Of the outpatient clinic registrations in 2013-14, 38.5%
reside in Nova Scotia Health Districts outside of Capital
while an additional 5.5% came from outside Nova Scotia.
Hematology New Semi-Urgent Consult
Ambulatory Care Clinic Average Wait Time (Days) by Quarter
QEII Health Sciences Centre, 2012 - 2014
3
50
Figure 19
40
Days
Days
2
Hematology Clinic Registrations
Summary Distribution of Patient Residency by Health District
QEII Health Sciences Centre, 2013- 2014
30
20
1
10
0
Average Wait Time
Standard Wait Time
Count
Minimum Wait
Maximum Wait
% Within Standard
Q1
12-13
1.0
2
74
0
10
95%
Q2
12-13
1.0
2
47
0
11
94%
Q3
12-13
1.2
2
51
0
18
92%
Q4
12-13
1.6
2
54
0
30
94%
Q1
13-14
0.7
2
82
0
10
96%
Source: PHS Data
Q2
13-14
1.2
2
70
0
26
91%
Q3
13-14
0.9
2
60
0
6
93%
Q4
13-14
0.5
2
62
0
4
97%
Prepared by DOM Information Office
Figure 16
0
Average Wait Time
Standard Wait Time
Count
Minimum Wait
Maximum Wait
% Within Standard
Out of Province: 607
Q1
12-13
29.2
42
160
0
189
83%
Q2
12-13
33.1
42
163
1
111
74%
Q3
12-13
29.9
42
135
2
108
82%
Q4
12-13
35.4
42
169
2
387
80%
Q1
13-14
34.8
42
176
1
348
76%
Source: PHS Data
Q2
13-14
33.9
42
146
1
168
78%
Q3
13-14
28.7
42
158
0
102
82%
Q4
13-14
32.4
42
144
1
123
79%
Hematology New Urgent Consult
Ambulatory Care Clinic Average Wait Time (Days) by Quarter
QEII Health Sciences Centre, 2012 - 2014
Source: STAR Data
120
100
10
Days
80
5
60
40
20
0
Average Wait Time
Standard Wait Time
Count
Minimum Wait
Maximum Wait
% Within Standard
94
Non Capital District:
4,269
Prepared by DOM Information Office
Hematology New Non-Urgent Consult
Ambulatory Care Clinic Average Wait Time (Days) by Quarter
QEII Health Sciences Centre, 2012 - 2014
15
Source: PHS Data
Capital District: 6,219
6 219
Figure 18
Days
DIVISION OF HEMATOLOGY
Figure 15
Q1
12-13
12.1
14
133
0
45
68%
Q2
12-13
9.2
14
107
0
25
88%
Q3
12-13
11.9
14
119
0
98
69%
Q4
12-13
13.6
14
114
0
62
73%
Q1
13-14
12.7
14
123
1
58
76%
Q2
13-14
11.7
14
131
1
62
79%
Q3
13-14
14.0
14
89
0
302
76%
Q4
13-14
12.5
14
118
1
53
65%
Prepared by DOM Information Office
0
Average Wait Time
Standard Wait Time
Count
Minimum Wait
Maximum Wait
% Within Standard
Source: PHS Data
Department of Medicine Compendium of Divisional Activity 2013-2014 — divisIon of HEMATOLOGY
Q1
12-13
85.0
90
117
0
219
60%
Q2
12-13
89.8
90
177
1
389
61%
Q3
12-13
75.4
90
189
2
377
71%
Q4
12-13
61.1
90
186
1
407
81%
Q1
13-14
83.1
90
145
6
405
70%
Q2
13-14
83.6
90
190
1
506
70%
Q3
13-14
76.6
90
246
2
520
69%
Q4
13-14
100.6
90
201
2
544
65%
Prepared by DOM Information Office
Prepared by DOM Information Office
Education
Most ambulatory Hematology care at the QEII HSC occurred in the Medical Day Unit. This activity accounted for 65.9% of the
activity of the MDU during the year. There were 16,576 patients registered in five subspecialty programs in the Medical Day
Unit in 2013-14, representing a 0.6% decrease in total activity from the previous year.
All hematologists were involved in the provision of medical
education during the year.
Figure 20
Hematologists provided 4 weeks of attending service on
the MTU, 35 shifts as Internist on-call to the Emergency
Department during the 2013-14 academic year.
Figure 22
Hematology Medical Day Unit Registrations
Summary Distribution of Patient Residency by Health District
QEII Health Sciences Centre, 2013 - 2014
Hematology Medical Day Unit
Proportion of Total Medical Day Unit Registrations
QEII Health Sciences Centre, 2009 - 2014
18,000
Undergraduate Medical Education
16,000
14,000
Registrations
12,000
Out of Province: 1,126
10,000
Capital District: 7,028
8,000
The division provided 32 core and elective rotations and
over 136 hours of undergraduate education.
Postgraduate Medical Education
6,000
4,000
2,000
0
Total Medical Day Unit
Total Hematology
Percent Hematology
2009-2010
13,068
9,388
71.8%
2010-2011
14,518
10,124
69.7%
2011-2012
15,761
10,650
67.6%
Source: STAR Data
2012-2013
16,678
11,648
69.8%
Non Capital District:
2,764
2013-2014
16,576
10,918
65.9%
Prepared by DOM Information Office
Figure 21
Source: STAR Data
Prepared by DOM Information Office
58 residents rotated through the Hematology service during
the 2013-14 academic year, including 19 externals from
Pathology, Nuclear Medicine, Family Medicine, Hematologic
Pathology, Anaesthesia, Radiation Oncology and Neurology
residency training programs.
Division members delivered 9 hours of Academic Half Day
teaching, 9 hours of CaRMS Selection Process and 10
hours as examiners for the Resident OSCE in the 2013-14
academic year.
Hematology Medical Day Unit
Ambulatory Care Registrations
QEII Health Sciences Centre, 2009 - 2014
14,000
12,000
Subspecialty Medical Education
R
Registrations
10,000
8,000
6,000
4,000
2,000
0
MDU Bone Marrow
MDU Oncology
MDU Apheresis Bone Marrow
MDU Apheresis Hematology
MDU Hematology
Total
Source: STAR Data
20092010
0
0
46
182
9,160
9,388
20102011
0
35
6
149
9,934
10,124
20112012
0
210
8
179
10,253
10,650
20122013
1
588
26
159
10,874
11,648
20132014
298
3,407
279
420
6,514
10,918
Prepared by DOM Information Office
The Division of Hematology offers a two-year Hematology
residency training program, fully accredited by the Royal
College of Physicians & Surgeons of Canada.
Dr. Sharif completed Hematology residency training
December 17, 2013 and is now working at George Dumont
Hospital, Moncton, NB. Dr. Zed completed Hematology
residency training June 30, 2014 and is now working at
Saint John Regional Hospital, Saint John, NB.
Dr. Katherine MacInnes was accepted to the Hematology
Fellowship Training Program to start on July 1, 2014.
Department of Medicine Compendium of Divisional Activity 2013-2014 — divisIon of HEMATOLOGY
95
DIVISION OF HEMATOLOGY
Medical Day Unit (MDU)
DIVISION OF HEMATOLOGY
Continuing Medical Education
Hematologists were active in the provision of continuing
medical education, with 31 sessions presented to general
practitioners, specialists and other trainees in 2013-14.
Research
Administration
Division members continue to maintain positions of
prominence within the National Cancer Institute of Canada
Clinical Trials Group (NCIC CTG). Members are also leaders
in clinical research in thromboembolic and major bleeding
disorders
Hematologists performed the following administrative
activities:
16 peer reviewed, 1 non-peer reviewed publications and
16 abstracts were presented at National/International
scientific meetings in 2013-14.
•• Division members act as Directors/Head/Chairs for:
Hematologists provided referee and editorial services for 4
journals/granting agencies during 2013-14.
The Division generated $2,716,794 in research grants and
industry contracts during 2013-14.
•• Division Head, including all responsibilities of the
position.
––
––
––
––
––
––
––
––
––
––
––
––
––
––
96
Department of Medicine Compendium of Divisional Activity 2013-2014 — divisIon of HEMATOLOGY
Director, Bleeding Disorder Program
Medical Director, BMT Program
Quality Director, BMT Program
Chair, Hematology Research Finance Committee
Chair, Hematology Residency Training Committee
Chair, Hematology Tumor Site Group
Chair, Hematology Morbidity & Mortality Committee
Director, Postgraduate Medical Education
Committee
Director, Thrombosis and Anticoagulation Program
Director, Undergraduate Medical Education
Chair, Resident Research Committee
Co-Chair, Research Ethics Board
Chair, Thrombosis Canada Fellowship Committee
Director, High Risk Obstetrics Clinic